img

Global Dermal Filler and Botolinum Toxin Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Dermal Filler and Botolinum Toxin Market Insights, Forecast to 2034

This report studies the dermal filler and botolinum toxin market. Dermal filler and botolinum toxin can be used for the cosmetic treatment of facial lines, and the rejuvenation of skin and underlying tissues.
Global Dermal Filler and Botolinum Toxin market is expected to reach to US$ 13910 million in 2024, with a positive growth of %, compared with US$ 12050 million in 2022. Backed with the increasing demand from downstream industries, Dermal Filler and Botolinum Toxin industry is evaluated to reach US$ 30390 million in 2029. The CAGR will be 13.9% during 2024 to 2029.
Demand in the dermal fillers and botulinum toxin market will continue to remain strong, offsetting any industry margincompression.Additionally, increasing research & development(R&D) initiatives to extend the therapeutic botulinumapplications of botulinum toxin and a rising number of cosmetic issues are some of the key drivers of the dermal fillers and botulinum toxin market. Botulinum toxin is a non-invasive cosmetic procedure, which is used to treat a wide variety of cosmetic issues, includingforehead creases and fine lines on the face. Due to its minimal pain and downtime, as well as its long-lasting effects,botulinum toxin treatments are becoming more popular among patients getting facelfts. As it has few side effects andcan be used several times a year for maximum outcomes, botulinum toxin has received particularly positivereviews. This factor would further boost the sale of botulinum toxin treatments in the forecast period.
Report Covers
This report presents an overview of global Dermal Filler and Botolinum Toxin market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Dermal Filler and Botolinum Toxin market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Allergan
Galderma
Merz Pharma GmbH & Co. KGaA
Anika Therapeutics
Suneva Medical
Contura
HUGEL
Grex Pharma
Daewoong Pharmaceuticals
Medy-Tox
TEOXANE Laboratories
SciVision Biotech
Segment by Type
Hyaluronic Acid Based Fillers
Non-Hyaluronic Acid Based Fillers
Botulinum Toxin

Segment by Application


Aesthetic Restoration
Wrinkle Reduction

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Dermal Filler and Botolinum Toxin plant distribution, commercial date of Dermal Filler and Botolinum Toxin, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Dermal Filler and Botolinum Toxin introduction, etc. Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Dermal Filler and Botolinum Toxin
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Dermal Filler and Botolinum Toxin Product Introduction
1.2 Market by Type
1.2.1 Global Dermal Filler and Botolinum Toxin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Hyaluronic Acid Based Fillers
1.2.3 Non-Hyaluronic Acid Based Fillers
1.2.4 Botulinum Toxin
1.3 Market by Application
1.3.1 Global Dermal Filler and Botolinum Toxin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Aesthetic Restoration
1.3.3 Wrinkle Reduction
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Dermal Filler and Botolinum Toxin Sales Estimates and Forecasts 2018-2029
2.2 Global Dermal Filler and Botolinum Toxin Revenue by Region
2.2.1 Global Dermal Filler and Botolinum Toxin Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Dermal Filler and Botolinum Toxin Revenue by Region (2018-2024)
2.2.3 Global Dermal Filler and Botolinum Toxin Revenue by Region (2024-2029)
2.2.4 Global Dermal Filler and Botolinum Toxin Revenue Market Share by Region (2018-2029)
2.3 Global Dermal Filler and Botolinum Toxin Sales Estimates and Forecasts 2018-2029
2.4 Global Dermal Filler and Botolinum Toxin Sales by Region
2.4.1 Global Dermal Filler and Botolinum Toxin Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Dermal Filler and Botolinum Toxin Sales by Region (2018-2024)
2.4.3 Global Dermal Filler and Botolinum Toxin Sales by Region (2024-2029)
2.4.4 Global Dermal Filler and Botolinum Toxin Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Dermal Filler and Botolinum Toxin Sales by Manufacturers
3.1.1 Global Dermal Filler and Botolinum Toxin Sales by Manufacturers (2018-2024)
3.1.2 Global Dermal Filler and Botolinum Toxin Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Dermal Filler and Botolinum Toxin in 2022
3.2 Global Dermal Filler and Botolinum Toxin Revenue by Manufacturers
3.2.1 Global Dermal Filler and Botolinum Toxin Revenue by Manufacturers (2018-2024)
3.2.2 Global Dermal Filler and Botolinum Toxin Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Dermal Filler and Botolinum Toxin Revenue in 2022
3.3 Global Key Players of Dermal Filler and Botolinum Toxin, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Dermal Filler and Botolinum Toxin Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Dermal Filler and Botolinum Toxin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Dermal Filler and Botolinum Toxin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Dermal Filler and Botolinum Toxin, Product Offered and Application
3.8 Global Key Manufacturers of Dermal Filler and Botolinum Toxin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Dermal Filler and Botolinum Toxin Sales by Type
4.1.1 Global Dermal Filler and Botolinum Toxin Historical Sales by Type (2018-2024)
4.1.2 Global Dermal Filler and Botolinum Toxin Forecasted Sales by Type (2024-2029)
4.1.3 Global Dermal Filler and Botolinum Toxin Sales Market Share by Type (2018-2029)
4.2 Global Dermal Filler and Botolinum Toxin Revenue by Type
4.2.1 Global Dermal Filler and Botolinum Toxin Historical Revenue by Type (2018-2024)
4.2.2 Global Dermal Filler and Botolinum Toxin Forecasted Revenue by Type (2024-2029)
4.2.3 Global Dermal Filler and Botolinum Toxin Revenue Market Share by Type (2018-2029)
4.3 Global Dermal Filler and Botolinum Toxin Price by Type
4.3.1 Global Dermal Filler and Botolinum Toxin Price by Type (2018-2024)
4.3.2 Global Dermal Filler and Botolinum Toxin Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Dermal Filler and Botolinum Toxin Sales by Application
5.1.1 Global Dermal Filler and Botolinum Toxin Historical Sales by Application (2018-2024)
5.1.2 Global Dermal Filler and Botolinum Toxin Forecasted Sales by Application (2024-2029)
5.1.3 Global Dermal Filler and Botolinum Toxin Sales Market Share by Application (2018-2029)
5.2 Global Dermal Filler and Botolinum Toxin Revenue by Application
5.2.1 Global Dermal Filler and Botolinum Toxin Historical Revenue by Application (2018-2024)
5.2.2 Global Dermal Filler and Botolinum Toxin Forecasted Revenue by Application (2024-2029)
5.2.3 Global Dermal Filler and Botolinum Toxin Revenue Market Share by Application (2018-2029)
5.3 Global Dermal Filler and Botolinum Toxin Price by Application
5.3.1 Global Dermal Filler and Botolinum Toxin Price by Application (2018-2024)
5.3.2 Global Dermal Filler and Botolinum Toxin Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Dermal Filler and Botolinum Toxin Market Size by Type
6.1.1 US & Canada Dermal Filler and Botolinum Toxin Sales by Type (2018-2029)
6.1.2 US & Canada Dermal Filler and Botolinum Toxin Revenue by Type (2018-2029)
6.2 US & Canada Dermal Filler and Botolinum Toxin Market Size by Application
6.2.1 US & Canada Dermal Filler and Botolinum Toxin Sales by Application (2018-2029)
6.2.2 US & Canada Dermal Filler and Botolinum Toxin Revenue by Application (2018-2029)
6.3 US & Canada Dermal Filler and Botolinum Toxin Market Size by Country
6.3.1 US & Canada Dermal Filler and Botolinum Toxin Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Dermal Filler and Botolinum Toxin Sales by Country (2018-2029)
6.3.3 US & Canada Dermal Filler and Botolinum Toxin Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Dermal Filler and Botolinum Toxin Market Size by Type
7.1.1 Europe Dermal Filler and Botolinum Toxin Sales by Type (2018-2029)
7.1.2 Europe Dermal Filler and Botolinum Toxin Revenue by Type (2018-2029)
7.2 Europe Dermal Filler and Botolinum Toxin Market Size by Application
7.2.1 Europe Dermal Filler and Botolinum Toxin Sales by Application (2018-2029)
7.2.2 Europe Dermal Filler and Botolinum Toxin Revenue by Application (2018-2029)
7.3 Europe Dermal Filler and Botolinum Toxin Market Size by Country
7.3.1 Europe Dermal Filler and Botolinum Toxin Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Dermal Filler and Botolinum Toxin Sales by Country (2018-2029)
7.3.3 Europe Dermal Filler and Botolinum Toxin Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Dermal Filler and Botolinum Toxin Market Size
8.1.1 China Dermal Filler and Botolinum Toxin Sales (2018-2029)
8.1.2 China Dermal Filler and Botolinum Toxin Revenue (2018-2029)
8.2 China Dermal Filler and Botolinum Toxin Market Size by Application
8.2.1 China Dermal Filler and Botolinum Toxin Sales by Application (2018-2029)
8.2.2 China Dermal Filler and Botolinum Toxin Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Dermal Filler and Botolinum Toxin Market Size by Type
9.1.1 Asia Dermal Filler and Botolinum Toxin Sales by Type (2018-2029)
9.1.2 Asia Dermal Filler and Botolinum Toxin Revenue by Type (2018-2029)
9.2 Asia Dermal Filler and Botolinum Toxin Market Size by Application
9.2.1 Asia Dermal Filler and Botolinum Toxin Sales by Application (2018-2029)
9.2.2 Asia Dermal Filler and Botolinum Toxin Revenue by Application (2018-2029)
9.3 Asia Dermal Filler and Botolinum Toxin Sales by Region
9.3.1 Asia Dermal Filler and Botolinum Toxin Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Dermal Filler and Botolinum Toxin Revenue by Region (2018-2029)
9.3.3 Asia Dermal Filler and Botolinum Toxin Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Dermal Filler and Botolinum Toxin Market Size by Type
10.1.1 Middle East, Africa and Latin America Dermal Filler and Botolinum Toxin Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Dermal Filler and Botolinum Toxin Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Dermal Filler and Botolinum Toxin Market Size by Application
10.2.1 Middle East, Africa and Latin America Dermal Filler and Botolinum Toxin Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Dermal Filler and Botolinum Toxin Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Dermal Filler and Botolinum Toxin Sales by Country
10.3.1 Middle East, Africa and Latin America Dermal Filler and Botolinum Toxin Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Dermal Filler and Botolinum Toxin Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Dermal Filler and Botolinum Toxin Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Allergan
11.1.1 Allergan Company Information
11.1.2 Allergan Overview
11.1.3 Allergan Dermal Filler and Botolinum Toxin Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Allergan Dermal Filler and Botolinum Toxin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Allergan Recent Developments
11.2 Galderma
11.2.1 Galderma Company Information
11.2.2 Galderma Overview
11.2.3 Galderma Dermal Filler and Botolinum Toxin Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Galderma Dermal Filler and Botolinum Toxin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Galderma Recent Developments
11.3 Merz Pharma GmbH & Co. KGaA
11.3.1 Merz Pharma GmbH & Co. KGaA Company Information
11.3.2 Merz Pharma GmbH & Co. KGaA Overview
11.3.3 Merz Pharma GmbH & Co. KGaA Dermal Filler and Botolinum Toxin Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Merz Pharma GmbH & Co. KGaA Dermal Filler and Botolinum Toxin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merz Pharma GmbH & Co. KGaA Recent Developments
11.4 Anika Therapeutics
11.4.1 Anika Therapeutics Company Information
11.4.2 Anika Therapeutics Overview
11.4.3 Anika Therapeutics Dermal Filler and Botolinum Toxin Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Anika Therapeutics Dermal Filler and Botolinum Toxin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Anika Therapeutics Recent Developments
11.5 Suneva Medical
11.5.1 Suneva Medical Company Information
11.5.2 Suneva Medical Overview
11.5.3 Suneva Medical Dermal Filler and Botolinum Toxin Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Suneva Medical Dermal Filler and Botolinum Toxin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Suneva Medical Recent Developments
11.6 Contura
11.6.1 Contura Company Information
11.6.2 Contura Overview
11.6.3 Contura Dermal Filler and Botolinum Toxin Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Contura Dermal Filler and Botolinum Toxin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Contura Recent Developments
11.7 HUGEL
11.7.1 HUGEL Company Information
11.7.2 HUGEL Overview
11.7.3 HUGEL Dermal Filler and Botolinum Toxin Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 HUGEL Dermal Filler and Botolinum Toxin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 HUGEL Recent Developments
11.8 Grex Pharma
11.8.1 Grex Pharma Company Information
11.8.2 Grex Pharma Overview
11.8.3 Grex Pharma Dermal Filler and Botolinum Toxin Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Grex Pharma Dermal Filler and Botolinum Toxin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Grex Pharma Recent Developments
11.9 Daewoong Pharmaceuticals
11.9.1 Daewoong Pharmaceuticals Company Information
11.9.2 Daewoong Pharmaceuticals Overview
11.9.3 Daewoong Pharmaceuticals Dermal Filler and Botolinum Toxin Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Daewoong Pharmaceuticals Dermal Filler and Botolinum Toxin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Daewoong Pharmaceuticals Recent Developments
11.10 Medy-Tox
11.10.1 Medy-Tox Company Information
11.10.2 Medy-Tox Overview
11.10.3 Medy-Tox Dermal Filler and Botolinum Toxin Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Medy-Tox Dermal Filler and Botolinum Toxin Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Medy-Tox Recent Developments
11.11 TEOXANE Laboratories
11.11.1 TEOXANE Laboratories Company Information
11.11.2 TEOXANE Laboratories Overview
11.11.3 TEOXANE Laboratories Dermal Filler and Botolinum Toxin Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 TEOXANE Laboratories Dermal Filler and Botolinum Toxin Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 TEOXANE Laboratories Recent Developments
11.12 SciVision Biotech
11.12.1 SciVision Biotech Company Information
11.12.2 SciVision Biotech Overview
11.12.3 SciVision Biotech Dermal Filler and Botolinum Toxin Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 SciVision Biotech Dermal Filler and Botolinum Toxin Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 SciVision Biotech Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Dermal Filler and Botolinum Toxin Industry Chain Analysis
12.2 Dermal Filler and Botolinum Toxin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Dermal Filler and Botolinum Toxin Production Mode & Process
12.4 Dermal Filler and Botolinum Toxin Sales and Marketing
12.4.1 Dermal Filler and Botolinum Toxin Sales Channels
12.4.2 Dermal Filler and Botolinum Toxin Distributors
12.5 Dermal Filler and Botolinum Toxin Customers
13 Market Dynamics
13.1 Dermal Filler and Botolinum Toxin Industry Trends
13.2 Dermal Filler and Botolinum Toxin Market Drivers
13.3 Dermal Filler and Botolinum Toxin Market Challenges
13.4 Dermal Filler and Botolinum Toxin Market Restraints
14 Key Findings in The Global Dermal Filler and Botolinum Toxin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Dermal Filler and Botolinum Toxin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Hyaluronic Acid Based Fillers
Table 3. Major Manufacturers of Non-Hyaluronic Acid Based Fillers
Table 4. Major Manufacturers of Botulinum Toxin
Table 5. Global Dermal Filler and Botolinum Toxin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Dermal Filler and Botolinum Toxin Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Dermal Filler and Botolinum Toxin Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Dermal Filler and Botolinum Toxin Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Dermal Filler and Botolinum Toxin Revenue Market Share by Region (2018-2024)
Table 10. Global Dermal Filler and Botolinum Toxin Revenue Market Share by Region (2024-2029)
Table 11. Global Dermal Filler and Botolinum Toxin Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Dermal Filler and Botolinum Toxin Sales by Region (2018-2024) & (K MT)
Table 13. Global Dermal Filler and Botolinum Toxin Sales by Region (2024-2029) & (K MT)
Table 14. Global Dermal Filler and Botolinum Toxin Sales Market Share by Region (2018-2024)
Table 15. Global Dermal Filler and Botolinum Toxin Sales Market Share by Region (2024-2029)
Table 16. Global Dermal Filler and Botolinum Toxin Sales by Manufacturers (2018-2024) & (K MT)
Table 17. Global Dermal Filler and Botolinum Toxin Sales Share by Manufacturers (2018-2024)
Table 18. Global Dermal Filler and Botolinum Toxin Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Dermal Filler and Botolinum Toxin Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Dermal Filler and Botolinum Toxin, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Dermal Filler and Botolinum Toxin Price by Manufacturers 2018-2024 (USD/MT)
Table 22. Global Dermal Filler and Botolinum Toxin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Dermal Filler and Botolinum Toxin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermal Filler and Botolinum Toxin as of 2022)
Table 24. Global Key Manufacturers of Dermal Filler and Botolinum Toxin, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Dermal Filler and Botolinum Toxin, Product Offered and Application
Table 26. Global Key Manufacturers of Dermal Filler and Botolinum Toxin, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Dermal Filler and Botolinum Toxin Sales by Type (2018-2024) & (K MT)
Table 29. Global Dermal Filler and Botolinum Toxin Sales by Type (2024-2029) & (K MT)
Table 30. Global Dermal Filler and Botolinum Toxin Sales Share by Type (2018-2024)
Table 31. Global Dermal Filler and Botolinum Toxin Sales Share by Type (2024-2029)
Table 32. Global Dermal Filler and Botolinum Toxin Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Dermal Filler and Botolinum Toxin Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Dermal Filler and Botolinum Toxin Revenue Share by Type (2018-2024)
Table 35. Global Dermal Filler and Botolinum Toxin Revenue Share by Type (2024-2029)
Table 36. Dermal Filler and Botolinum Toxin Price by Type (2018-2024) & (USD/MT)
Table 37. Global Dermal Filler and Botolinum Toxin Price Forecast by Type (2024-2029) & (USD/MT)
Table 38. Global Dermal Filler and Botolinum Toxin Sales by Application (2018-2024) & (K MT)
Table 39. Global Dermal Filler and Botolinum Toxin Sales by Application (2024-2029) & (K MT)
Table 40. Global Dermal Filler and Botolinum Toxin Sales Share by Application (2018-2024)
Table 41. Global Dermal Filler and Botolinum Toxin Sales Share by Application (2024-2029)
Table 42. Global Dermal Filler and Botolinum Toxin Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Dermal Filler and Botolinum Toxin Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Dermal Filler and Botolinum Toxin Revenue Share by Application (2018-2024)
Table 45. Global Dermal Filler and Botolinum Toxin Revenue Share by Application (2024-2029)
Table 46. Dermal Filler and Botolinum Toxin Price by Application (2018-2024) & (USD/MT)
Table 47. Global Dermal Filler and Botolinum Toxin Price Forecast by Application (2024-2029) & (USD/MT)
Table 48. US & Canada Dermal Filler and Botolinum Toxin Sales by Type (2018-2024) & (K MT)
Table 49. US & Canada Dermal Filler and Botolinum Toxin Sales by Type (2024-2029) & (K MT)
Table 50. US & Canada Dermal Filler and Botolinum Toxin Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Dermal Filler and Botolinum Toxin Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Dermal Filler and Botolinum Toxin Sales by Application (2018-2024) & (K MT)
Table 53. US & Canada Dermal Filler and Botolinum Toxin Sales by Application (2024-2029) & (K MT)
Table 54. US & Canada Dermal Filler and Botolinum Toxin Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Dermal Filler and Botolinum Toxin Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Dermal Filler and Botolinum Toxin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Dermal Filler and Botolinum Toxin Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Dermal Filler and Botolinum Toxin Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Dermal Filler and Botolinum Toxin Sales by Country (2018-2024) & (K MT)
Table 60. US & Canada Dermal Filler and Botolinum Toxin Sales by Country (2024-2029) & (K MT)
Table 61. Europe Dermal Filler and Botolinum Toxin Sales by Type (2018-2024) & (K MT)
Table 62. Europe Dermal Filler and Botolinum Toxin Sales by Type (2024-2029) & (K MT)
Table 63. Europe Dermal Filler and Botolinum Toxin Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Dermal Filler and Botolinum Toxin Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Dermal Filler and Botolinum Toxin Sales by Application (2018-2024) & (K MT)
Table 66. Europe Dermal Filler and Botolinum Toxin Sales by Application (2024-2029) & (K MT)
Table 67. Europe Dermal Filler and Botolinum Toxin Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Dermal Filler and Botolinum Toxin Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Dermal Filler and Botolinum Toxin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Dermal Filler and Botolinum Toxin Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Dermal Filler and Botolinum Toxin Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Dermal Filler and Botolinum Toxin Sales by Country (2018-2024) & (K MT)
Table 73. Europe Dermal Filler and Botolinum Toxin Sales by Country (2024-2029) & (K MT)
Table 74. China Dermal Filler and Botolinum Toxin Sales by Type (2018-2024) & (K MT)
Table 75. China Dermal Filler and Botolinum Toxin Sales by Type (2024-2029) & (K MT)
Table 76. China Dermal Filler and Botolinum Toxin Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Dermal Filler and Botolinum Toxin Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Dermal Filler and Botolinum Toxin Sales by Application (2018-2024) & (K MT)
Table 79. China Dermal Filler and Botolinum Toxin Sales by Application (2024-2029) & (K MT)
Table 80. China Dermal Filler and Botolinum Toxin Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Dermal Filler and Botolinum Toxin Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Dermal Filler and Botolinum Toxin Sales by Type (2018-2024) & (K MT)
Table 83. Asia Dermal Filler and Botolinum Toxin Sales by Type (2024-2029) & (K MT)
Table 84. Asia Dermal Filler and Botolinum Toxin Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Dermal Filler and Botolinum Toxin Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Dermal Filler and Botolinum Toxin Sales by Application (2018-2024) & (K MT)
Table 87. Asia Dermal Filler and Botolinum Toxin Sales by Application (2024-2029) & (K MT)
Table 88. Asia Dermal Filler and Botolinum Toxin Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Dermal Filler and Botolinum Toxin Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Dermal Filler and Botolinum Toxin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Dermal Filler and Botolinum Toxin Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Dermal Filler and Botolinum Toxin Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Dermal Filler and Botolinum Toxin Sales by Region (2018-2024) & (K MT)
Table 94. Asia Dermal Filler and Botolinum Toxin Sales by Region (2024-2029) & (K MT)
Table 95. Middle East, Africa and Latin America Dermal Filler and Botolinum Toxin Sales by Type (2018-2024) & (K MT)
Table 96. Middle East, Africa and Latin America Dermal Filler and Botolinum Toxin Sales by Type (2024-2029) & (K MT)
Table 97. Middle East, Africa and Latin America Dermal Filler and Botolinum Toxin Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Dermal Filler and Botolinum Toxin Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Dermal Filler and Botolinum Toxin Sales by Application (2018-2024) & (K MT)
Table 100. Middle East, Africa and Latin America Dermal Filler and Botolinum Toxin Sales by Application (2024-2029) & (K MT)
Table 101. Middle East, Africa and Latin America Dermal Filler and Botolinum Toxin Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Dermal Filler and Botolinum Toxin Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Dermal Filler and Botolinum Toxin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Dermal Filler and Botolinum Toxin Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Dermal Filler and Botolinum Toxin Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Dermal Filler and Botolinum Toxin Sales by Country (2018-2024) & (K MT)
Table 107. Middle East, Africa and Latin America Dermal Filler and Botolinum Toxin Sales by Country (2024-2029) & (K MT)
Table 108. Allergan Company Information
Table 109. Allergan Description and Major Businesses
Table 110. Allergan Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 111. Allergan Dermal Filler and Botolinum Toxin Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Allergan Recent Developments
Table 113. Galderma Company Information
Table 114. Galderma Description and Major Businesses
Table 115. Galderma Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 116. Galderma Dermal Filler and Botolinum Toxin Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Galderma Recent Developments
Table 118. Merz Pharma GmbH & Co. KGaA Company Information
Table 119. Merz Pharma GmbH & Co. KGaA Description and Major Businesses
Table 120. Merz Pharma GmbH & Co. KGaA Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 121. Merz Pharma GmbH & Co. KGaA Dermal Filler and Botolinum Toxin Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Merz Pharma GmbH & Co. KGaA Recent Developments
Table 123. Anika Therapeutics Company Information
Table 124. Anika Therapeutics Description and Major Businesses
Table 125. Anika Therapeutics Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 126. Anika Therapeutics Dermal Filler and Botolinum Toxin Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Anika Therapeutics Recent Developments
Table 128. Suneva Medical Company Information
Table 129. Suneva Medical Description and Major Businesses
Table 130. Suneva Medical Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 131. Suneva Medical Dermal Filler and Botolinum Toxin Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Suneva Medical Recent Developments
Table 133. Contura Company Information
Table 134. Contura Description and Major Businesses
Table 135. Contura Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 136. Contura Dermal Filler and Botolinum Toxin Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Contura Recent Developments
Table 138. HUGEL Company Information
Table 139. HUGEL Description and Major Businesses
Table 140. HUGEL Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 141. HUGEL Dermal Filler and Botolinum Toxin Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. HUGEL Recent Developments
Table 143. Grex Pharma Company Information
Table 144. Grex Pharma Description and Major Businesses
Table 145. Grex Pharma Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 146. Grex Pharma Dermal Filler and Botolinum Toxin Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Grex Pharma Recent Developments
Table 148. Daewoong Pharmaceuticals Company Information
Table 149. Daewoong Pharmaceuticals Description and Major Businesses
Table 150. Daewoong Pharmaceuticals Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 151. Daewoong Pharmaceuticals Dermal Filler and Botolinum Toxin Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Daewoong Pharmaceuticals Recent Developments
Table 153. Medy-Tox Company Information
Table 154. Medy-Tox Description and Major Businesses
Table 155. Medy-Tox Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 156. Medy-Tox Dermal Filler and Botolinum Toxin Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Medy-Tox Recent Developments
Table 158. TEOXANE Laboratories Company Information
Table 159. TEOXANE Laboratories Description and Major Businesses
Table 160. TEOXANE Laboratories Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 161. TEOXANE Laboratories Dermal Filler and Botolinum Toxin Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. TEOXANE Laboratories Recent Developments
Table 163. SciVision Biotech Company Information
Table 164. SciVision Biotech Description and Major Businesses
Table 165. SciVision Biotech Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 166. SciVision Biotech Dermal Filler and Botolinum Toxin Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. SciVision Biotech Recent Developments
Table 168. Key Raw Materials Lists
Table 169. Raw Materials Key Suppliers Lists
Table 170. Dermal Filler and Botolinum Toxin Distributors List
Table 171. Dermal Filler and Botolinum Toxin Customers List
Table 172. Dermal Filler and Botolinum Toxin Market Trends
Table 173. Dermal Filler and Botolinum Toxin Market Drivers
Table 174. Dermal Filler and Botolinum Toxin Market Challenges
Table 175. Dermal Filler and Botolinum Toxin Market Restraints
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Dermal Filler and Botolinum Toxin Product Picture
Figure 2. Global Dermal Filler and Botolinum Toxin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Dermal Filler and Botolinum Toxin Market Share by Type in 2022 & 2029
Figure 4. Hyaluronic Acid Based Fillers Product Picture
Figure 5. Non-Hyaluronic Acid Based Fillers Product Picture
Figure 6. Botulinum Toxin Product Picture
Figure 7. Global Dermal Filler and Botolinum Toxin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Dermal Filler and Botolinum Toxin Market Share by Application in 2022 & 2029
Figure 9. Aesthetic Restoration
Figure 10. Wrinkle Reduction
Figure 11. Dermal Filler and Botolinum Toxin Report Years Considered
Figure 12. Global Dermal Filler and Botolinum Toxin Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Dermal Filler and Botolinum Toxin Revenue 2018-2029 (US$ Million)
Figure 14. Global Dermal Filler and Botolinum Toxin Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Dermal Filler and Botolinum Toxin Revenue Market Share by Region (2018-2029)
Figure 16. Global Dermal Filler and Botolinum Toxin Sales 2018-2029 ((K MT)
Figure 17. Global Dermal Filler and Botolinum Toxin Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Dermal Filler and Botolinum Toxin Sales YoY (2018-2029) & (K MT)
Figure 19. US & Canada Dermal Filler and Botolinum Toxin Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Dermal Filler and Botolinum Toxin Sales YoY (2018-2029) & (K MT)
Figure 21. Europe Dermal Filler and Botolinum Toxin Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Dermal Filler and Botolinum Toxin Sales YoY (2018-2029) & (K MT)
Figure 23. China Dermal Filler and Botolinum Toxin Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Dermal Filler and Botolinum Toxin Sales YoY (2018-2029) & (K MT)
Figure 25. Asia (excluding China) Dermal Filler and Botolinum Toxin Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Dermal Filler and Botolinum Toxin Sales YoY (2018-2029) & (K MT)
Figure 27. Middle East, Africa and Latin America Dermal Filler and Botolinum Toxin Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Dermal Filler and Botolinum Toxin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Dermal Filler and Botolinum Toxin in the World: Market Share by Dermal Filler and Botolinum Toxin Revenue in 2022
Figure 30. Global Dermal Filler and Botolinum Toxin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Dermal Filler and Botolinum Toxin Sales Market Share by Type (2018-2029)
Figure 32. Global Dermal Filler and Botolinum Toxin Revenue Market Share by Type (2018-2029)
Figure 33. Global Dermal Filler and Botolinum Toxin Sales Market Share by Application (2018-2029)
Figure 34. Global Dermal Filler and Botolinum Toxin Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Dermal Filler and Botolinum Toxin Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Dermal Filler and Botolinum Toxin Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Dermal Filler and Botolinum Toxin Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Dermal Filler and Botolinum Toxin Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Dermal Filler and Botolinum Toxin Revenue Share by Country (2018-2029)
Figure 40. US & Canada Dermal Filler and Botolinum Toxin Sales Share by Country (2018-2029)
Figure 41. U.S. Dermal Filler and Botolinum Toxin Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Dermal Filler and Botolinum Toxin Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Dermal Filler and Botolinum Toxin Sales Market Share by Type (2018-2029)
Figure 44. Europe Dermal Filler and Botolinum Toxin Revenue Market Share by Type (2018-2029)
Figure 45. Europe Dermal Filler and Botolinum Toxin Sales Market Share by Application (2018-2029)
Figure 46. Europe Dermal Filler and Botolinum Toxin Revenue Market Share by Application (2018-2029)
Figure 47. Europe Dermal Filler and Botolinum Toxin Revenue Share by Country (2018-2029)
Figure 48. Europe Dermal Filler and Botolinum Toxin Sales Share by Country (2018-2029)
Figure 49. Germany Dermal Filler and Botolinum Toxin Revenue (2018-2029) & (US$ Million)
Figure 50. France Dermal Filler and Botolinum Toxin Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Dermal Filler and Botolinum Toxin Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Dermal Filler and Botolinum Toxin Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Dermal Filler and Botolinum Toxin Revenue (2018-2029) & (US$ Million)
Figure 54. China Dermal Filler and Botolinum Toxin Sales Market Share by Type (2018-2029)
Figure 55. China Dermal Filler and Botolinum Toxin Revenue Market Share by Type (2018-2029)
Figure 56. China Dermal Filler and Botolinum Toxin Sales Market Share by Application (2018-2029)
Figure 57. China Dermal Filler and Botolinum Toxin Revenue Market Share by Application (2018-2029)
Figure 58. Asia Dermal Filler and Botolinum Toxin Sales Market Share by Type (2018-2029)
Figure 59. Asia Dermal Filler and Botolinum Toxin Revenue Market Share by Type (2018-2029)
Figure 60. Asia Dermal Filler and Botolinum Toxin Sales Market Share by Application (2018-2029)
Figure 61. Asia Dermal Filler and Botolinum Toxin Revenue Market Share by Application (2018-2029)
Figure 62. Asia Dermal Filler and Botolinum Toxin Revenue Share by Region (2018-2029)
Figure 63. Asia Dermal Filler and Botolinum Toxin Sales Share by Region (2018-2029)
Figure 64. Japan Dermal Filler and Botolinum Toxin Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Dermal Filler and Botolinum Toxin Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Dermal Filler and Botolinum Toxin Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Dermal Filler and Botolinum Toxin Revenue (2018-2029) & (US$ Million)
Figure 68. India Dermal Filler and Botolinum Toxin Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Dermal Filler and Botolinum Toxin Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Dermal Filler and Botolinum Toxin Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Dermal Filler and Botolinum Toxin Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Dermal Filler and Botolinum Toxin Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Dermal Filler and Botolinum Toxin Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Dermal Filler and Botolinum Toxin Sales Share by Country (2018-2029)
Figure 75. Brazil Dermal Filler and Botolinum Toxin Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Dermal Filler and Botolinum Toxin Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Dermal Filler and Botolinum Toxin Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Dermal Filler and Botolinum Toxin Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Dermal Filler and Botolinum Toxin Revenue (2018-2029) & (US$ Million)
Figure 80. Dermal Filler and Botolinum Toxin Value Chain
Figure 81. Dermal Filler and Botolinum Toxin Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed